These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19603191)

  • 1. Limitations of dual x-ray absorptiometry in children with chronic kidney disease.
    Weber LT; Mehls O
    Pediatr Nephrol; 2010 Jan; 25(1):3-5. PubMed ID: 19603191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dual energy X-ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease-mineral and bone disorders.
    Pocock N
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():19-21. PubMed ID: 28429557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease and bone fracture: a growing concern.
    Nickolas TL; Leonard MB; Shane E
    Kidney Int; 2008 Sep; 74(6):721-31. PubMed ID: 18563052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive Summary of the 2015 ISCD Position Development Conference on Advanced Measures From DXA and QCT: Fracture Prediction Beyond BMD.
    Shepherd JA; Schousboe JT; Broy SB; Engelke K; Leslie WD
    J Clin Densitom; 2015; 18(3):274-86. PubMed ID: 26277847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeating Measurement of Bone Mineral Density when Monitoring with Dual-energy X-ray Absorptiometry: 2019 ISCD Official Position.
    Kendler DL; Compston J; Carey JJ; Wu CH; Ibrahim A; Lewiecki EM
    J Clin Densitom; 2019; 22(4):489-500. PubMed ID: 31378452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of osteoporosis in patients with chronic kidney disease.
    Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
    Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.
    Jannot M; Mac-Way F; Lapierre V; Lafage-Proust MH
    J Nephrol; 2017 Oct; 30(5):635-643. PubMed ID: 28900872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management.
    Babayev R; Nickolas TL
    Semin Dial; 2015; 28(6):645-53. PubMed ID: 26332760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to predict and treat increased fracture risk in chronic kidney disease.
    West SL; Patel P; Jamal SA
    J Intern Med; 2015 Jul; 278(1):19-28. PubMed ID: 25758353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKD-MBD after kidney transplantation.
    Wesseling-Perry K; Bacchetta J
    Pediatr Nephrol; 2011 Dec; 26(12):2143-51. PubMed ID: 21394466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Malluche HH; Monier-Faugere MC; Blomquist G; Davenport DL
    Osteoporos Int; 2018 Jan; 29(1):125-134. PubMed ID: 28993865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions.
    Bianchi ML; Leonard MB; Bechtold S; Högler W; Mughal MZ; Schönau E; Sylvester FA; Vogiatzi M; van den Heuvel-Eibrink MM; Ward L;
    J Clin Densitom; 2014; 17(2):281-94. PubMed ID: 24656723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between serum sclerostin level and bone density status in children on regular hemodialysis.
    Elsalam MA; El-Abden MZ; Mahmoud E; Zahab ZA; Ahmed H
    Saudi J Kidney Dis Transpl; 2019; 30(5):1022-1031. PubMed ID: 31696839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.
    McNerny EMB; Nickolas TL
    Curr Osteoporos Rep; 2017 Jun; 15(3):207-213. PubMed ID: 28447312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.
    Soeiro EMD; Castro L; Menezes R; Elias RM; Dos Reis LM; Jorgetti V; Moysés RMA
    Pediatr Nephrol; 2020 Jul; 35(7):1297-1305. PubMed ID: 32157445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of Quantitative Computed Tomography (QCT) of the Hip in the Management of Osteoporosis in Adults: the 2015 ISCD Official Positions-Part I.
    Engelke K; Lang T; Khosla S; Qin L; Zysset P; Leslie WD; Shepherd JA; Schousboe JT
    J Clin Densitom; 2015; 18(3):338-58. PubMed ID: 26277851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M; Sarihan H; Madenci E
    J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADDING VFA TO DXA IDENTIFIES FRACTURE RISK IN A WAY NOT DUPLICATED BY OTHER MEASURES.
    Ginther JP; Ginther AW; Brodersen LD
    Endocr Pract; 2017 Dec; 23(12):1375-1378. PubMed ID: 29019717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions.
    Rauch F; Plotkin H; DiMeglio L; Engelbert RH; Henderson RC; Munns C; Wenkert D; Zeitler P
    J Clin Densitom; 2008; 11(1):22-8. PubMed ID: 18442750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.